A detailed history of New Edge Advisors, LLC transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, New Edge Advisors, LLC holds 46 shares of IART stock, worth $1,325. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46
Previous 58 20.69%
Holding current value
$1,325
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$33.4 - $45.2 $400 - $542
-12 Reduced 20.69%
46 $1,000
Q4 2023

Feb 13, 2024

BUY
$34.21 - $44.59 $1,094 - $1,426
32 Added 123.08%
58 $2,000
Q3 2023

Nov 14, 2023

SELL
$37.8 - $45.97 $907 - $1,103
-24 Reduced 48.0%
26 $0
Q2 2023

Aug 14, 2023

SELL
$37.95 - $58.98 $175,291 - $272,428
-4,619 Reduced 98.93%
50 $2,000
Q1 2023

May 12, 2023

BUY
$52.61 - $60.49 $236,850 - $272,325
4,502 Added 2695.81%
4,669 $268,000
Q4 2022

Feb 14, 2023

BUY
$42.17 - $58.6 $7,042 - $9,786
167 New
167 $9,000

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $2.41B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.